Effect of Repetitive Administration of Doxorubicin-Containing Liposomes on Plasma Pharmacokinetics and Drug Biodistribution in a Rat Brain Tumor Model
- 15 December 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 11 (24) , 8856-8865
Abstract
Purpose: The incorporation of doxorubicin in long-circulating sterically stabilized liposomes (SSL-DXR) alters the pharmacokinetics and biodistribution of doxorubicin and therefore has the potential to alter the pharmacologic properties of doxorubicin. Previously, we showed that repetitive administration of SSL-DXR alters tumor vascular permeability. Experimental Design: Here, we investigated the effect of weekly i.v. injections of SSL-DXR on plasma pharmacokinetics and drug biodistribution in the orthotopic 9L rat brain tumor model. Results and Conclusions: The pharmacokinetics of free doxorubicin (5.67 mg/kg) did not change with repeat dosing. In contrast, drug concentrations in plasma and brain tumor increased and deposition in liver and spleen decreased after administration of the second of two weekly doses of SSL-DXR. Noncompartmental analysis and descriptive pharmacokinetic models were created to test hypotheses relating to the mechanisms responsible for alterations in SSL-DXR deposition. The analysis suggested that weekly administration of SSL-DXR significantly (P < 0.05) decreased the plasma elimination rate of SSL-DXR (34%) and decreased drug deposition in liver (2-fold) and spleen (3.5-fold). The pharmacokinetic model that best captured the observed 2.5-fold increase in tumor uptake of SSL-DXR mediated by repeat dosing was one that hypothesized that the rates of drug influx/efflux into tumor were increased by the first dose of SSL-DXR. Models that accounted only for residual drug deposited in the tissue or blood by the first weekly injection provided inferior fits to the data. Thus, the effects of repetitive dosing on SSL-DXR deposition in tumor are consistent with a treatment-mediated alteration of tumor vascular permeability.Keywords
This publication has 36 references indexed in Scilit:
- Quantification of Doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopyJournal of Chromatography B, 2004
- The Integration of Pharmacokinetics and Pharmacodynamics: Understanding Dose-ResponseAnnual Review of Pharmacology and Toxicology, 2004
- Targeting to macrophages: role of physicochemical properties of particulate carriers—liposomes and microspheres—on the phagocytosis by macrophagesJournal of Controlled Release, 2002
- Influence of dose on liposome clearance: critical role of blood proteinsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1996
- Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacyJournal of Neurosurgery, 1995
- Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation timesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1991
- Pharmacokinetics of stealth versus conventional liposomes: effect of doseBiochimica et Biophysica Acta (BBA) - Biomembranes, 1991
- Uptake and processing of liposomal phospholipids by Kupffer cells in vitroEuropean Journal of Biochemistry, 1985
- The effect of reticuloendothelial blockade on the blood clearance and tissue distribution of liposomesBiochimica et Biophysica Acta (BBA) - General Subjects, 1981
- Effect of plasma protein and tissue binding on the time course of drug concentration in plasmaJournal of Pharmacokinetics and Biopharmaceutics, 1979